Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.

Biotechnology

Enara Bio

Enara Bio's headquarters in United Kingdom

Anonymous

Scott Drutman MD

Stacey Davis

Sophie Papa

Joseph Dukes

David Watson

Kate Bingham

Adrian Hill

George Kassiotis

Josh Resnick

Eliezer Van Allen

Sadik Kassim

Mike Quigley

Mike Dybbs

Robert Ang

Charles Dunn

Drew Pardoll

This department conducts advanced research and development in scientific fields to drive innovation and discoveries.

Scientific Research

The Scientific Advisory Board at Enara Bio provides expert guidance and strategic insights to advance the company's research and development efforts. Comprised of leading scientists in the field, the board advises on the scientific validity and potential impact of novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, ensuring that Enara Bio's innovations align with current scientific advancements and clinical needs.

Scientific Advisory Board

This department manages facilities operations and environmental health and safety initiatives.

Facilities and EHS

The Directors team at Enara Bio is responsible for providing strategic leadership and oversight across various functional areas, including finance, human resources, intellectual property, IT, facilities, and biology. They work collaboratively to align departmental goals with the company's mission, ensuring cohesive and efficient operations that support the discovery and development of novel cancer immunotherapies.

Directors

This department focuses on analyzing and interpreting biological data using computational tools and techniques.

Bioinformatics Department

The Research and Development team at Enara Bio focuses on discovering and characterizing novel immunotherapy targets for cancer treatment. This multidisciplinary team leverages their expertise in immunopeptidomics, molecular immunology, cell process development, and bioinformatics to explore unconventional targets such as MR1-presented ligands and Dark Antigens™. Their work involves identifying and validating these novel targets, advancing preclinical research, and ultimately contributing to the development of next-generation cancer immunotherapies.

Enara Bio

Org chart

Board & advisors

Teams

Scientific Research

Scientific Advisory Board

Facilities and EHS

Directors

Bioinformatics Department

Research and Development

Offices

Enara Bio

Org chart

Board & advisors

Teams

Scientific Research

Scientific Advisory Board

Facilities and EHS

Directors

Bioinformatics Department

Research and Development

Offices

Related companies